5 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Deltanoid Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis DP001 softgel capsules, Placebo - Hyperparathyroidism, Secondary, Kidney Failure, Chronic | Phase 2 | Completed | Deltanoid Pharmaceuticals | 62 | 2013-09-01 | 2017-08-18 |
| A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism DP001 - Secondary Hyperparathyroidism | Phase 2 | Completed | Deltanoid Pharmaceuticals | 42 | 2012-08-01 | 2017-08-16 |
| Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis COL-121, 50 µg/g Calcipotriene Ointment, Placebo - Plaque-type Psoriasis | Phase 2 | Completed | Deltanoid Pharmaceuticals | 321 | 2008-01-01 | 2011-04-27 |
| Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density Placebo, DP001 - Osteoporosis | Phase 2 | Completed | Deltanoid Pharmaceuticals | 157 | 2007-03-01 | 2010-01-11 |
| Safety Study of an Oral Vitamin D Analog in Postmenopausal Women 2MD, Calcitriol, Placebo - Postmenopausal Osteoporosis, Multiple Sites | Phase 1 | Completed | Deltanoid Pharmaceuticals | 2017-07-27 |
Hyperparathyroidism, Secondary (2) · Kidney Failure, Chronic (1) · Osteoporosis (1) · Osteoporosis, Postmenopausal (1) · Psoriasis (1)
Calcitriol (1) · calcipotriene (1)
United States (4)
Ravi Thadhani, MD (2) · Michael Graeber, MD (1) · Wendy A Bedale, Ph.D. (1)